FIELD: medicine.
SUBSTANCE: method for facial rejuvenation consists in subdermal and intramuscular injections of botulinum toxin type A containing 500 units and diluted in normal saline in the pre-determined points of problem areas.
EFFECT: using the inventions allows providing the more effective facial rejuvenation in expression line correction, enables to prolong the clinical results when using minimum effective dosages with no side effects that leads to a harmonious appearance after the botulinum toxin therapy.
6 dwg, 3 ex
